Copyright
©The Author(s) 2021.
World J Gastroenterol. Nov 21, 2021; 27(43): 7546-7562
Published online Nov 21, 2021. doi: 10.3748/wjg.v27.i43.7546
Published online Nov 21, 2021. doi: 10.3748/wjg.v27.i43.7546
Figure 8 Dynamic changes in circulating tumor cell, mesenchymal circulating tumor cell, and survivin-positive circulating tumor cell counts following surgery.
A-C: The total circulating tumor cell (CTC) count, mesenchymal CTC proportion, and survivin-positive CTC count decreased dramatically 1 wk after resection. D: Increased survivin-positive CTC count in postoperative hepatocellular cancer patients (n = 10) at 1-12 mo before detectable recurrence or appearance of metastatic lesions, and decreased surviving-positive CTC count in the last 12 hepatocellular cancer patients with no recurrence. bP < 0.01. CTC: Circulating tumor cell.
- Citation: Yu J, Wang Z, Zhang H, Wang Y, Li DQ. Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma. World J Gastroenterol 2021; 27(43): 7546-7562
- URL: https://www.wjgnet.com/1007-9327/full/v27/i43/7546.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i43.7546